These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9267743)

  • 1. Lamotrigine-induced Stevens-Johnson syndrome: demonstration of specific lymphocyte reactivity in vitro.
    Sachs B; Rönnau AC; von Schmiedeberg S; Ruzicka T; Gleichmann E; Schuppe HC
    Dermatology; 1997; 195(1):60-4. PubMed ID: 9267743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stevens-Johnson syndrome associated with concomitant use of lamotrigine and valproic acid.
    Yalçin B; Karaduman A
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 2):898-9. PubMed ID: 11044815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor relevance of a lymphocyte proliferation assay in lamotrigine-induced Stevens-Johnson syndrome or toxic epidermal necrolysis.
    Tang YH; Mockenhaupt M; Henry A; Bounoua M; Naldi L; Le Gouvello S; Bensussan A; Roujeau JC
    Clin Exp Allergy; 2012 Feb; 42(2):248-54. PubMed ID: 22092454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamotrigine-induced severe cutaneous adverse reactions.
    Schlienger RG; Shapiro LE; Shear NH
    Epilepsia; 1998; 39 Suppl 7():S22-6. PubMed ID: 9798758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reintroduction of treatment with lamotrigine in combination with valproate after an initial allergic skin reaction].
    Gélisse P; Crespel A
    Rev Neurol (Paris); 2006 Nov; 162(11):1122-4. PubMed ID: 17086149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stevens-Johnson syndrome due to concomitant use of lamotrigine and valproic acid.
    Kocak S; Girisgin SA; Gul M; Cander B; Kaya H; Kaya E
    Am J Clin Dermatol; 2007; 8(2):107-11. PubMed ID: 17428116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early cyclosporine treatment of incipient toxic epidermal necrolysis induced by concomitant use of lamotrigine and sodium valproate.
    Hashim N; Bandara D; Tan E; Ilchyshyn A
    Acta Derm Venereol; 2004; 84(1):90-1. PubMed ID: 15040495
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lyell syndrome and Stevens-Johnson syndrome caused by lamotrigine].
    Bocquet H; Farmer M; Bressieux JM; Barzegar C; Jullien M; Soto B; Roujeau JC; Revuz J
    Ann Dermatol Venereol; 1999 Jan; 126(1):46-8. PubMed ID: 10095893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlating lamotrigine serum concentrations with tolerability in patients with epilepsy.
    Hirsch LJ; Weintraub D; Du Y; Buchsbaum R; Spencer HT; Hager M; Straka T; Bazil CW; Adams DJ; Resor SR; Morrell MJ
    Neurology; 2004 Sep; 63(6):1022-6. PubMed ID: 15452293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Stevens-Johnson syndrome after lamotrigine treatment].
    Campistol J; Geli M; Llistosella E; Molins J; Llobet M
    Rev Neurol; 1995; 23(124):1236-8. PubMed ID: 8556627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium valproate acutely inhibits lamotrigine metabolism.
    Yuen AW; Land G; Weatherley BC; Peck AW
    Br J Clin Pharmacol; 1992 May; 33(5):511-3. PubMed ID: 1524964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adding lamotrigine to valproate: incidence of rash and other adverse effects. Postmarketing Antiepileptic Drug Survey (PADS) Group.
    Faught E; Morris G; Jacobson M; French J; Harden C; Montouris G; Rosenfeld W
    Epilepsia; 1999 Aug; 40(8):1135-40. PubMed ID: 10448828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lyell syndrome associated with lamotrigine].
    Fernández-Calvo C; Olascoaga J; Resano A; Urcola J; Tuneu A; Zubizarreta J
    Rev Neurol; 2000 Dec 16-31; 31(12):1162-4. PubMed ID: 11205551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An active-control trial of lamotrigine monotherapy for partial seizures.
    Gilliam F; Vazquez B; Sackellares JC; Chang GY; Messenheimer J; Nyberg J; Risner ME; Rudd GD
    Neurology; 1998 Oct; 51(4):1018-25. PubMed ID: 9781523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe hypersensitivity syndrome to lamotrigine confirmed by lymphocyte stimulation in vitro.
    Schaub N; Bircher AJ
    Allergy; 2000 Feb; 55(2):191-3. PubMed ID: 10726736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics.
    Mockenhaupt M; Messenheimer J; Tennis P; Schlingmann J
    Neurology; 2005 Apr; 64(7):1134-8. PubMed ID: 15824335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamotrigine-induced severe cutaneous adverse reaction: Update data from 1999-2014.
    Wang XQ; Lv B; Wang HF; Zhang X; Yu SY; Huang XS; Zhang JT; Tian CL; Lang SY
    J Clin Neurosci; 2015 Jun; 22(6):1005-11. PubMed ID: 25913750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of long-term lamotrigine in epilepsy.
    Mackay FJ; Wilton LV; Pearce GL; Freemantle SN; Mann RD
    Epilepsia; 1997 Aug; 38(8):881-6. PubMed ID: 9579888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamotrigine and toxic epidermal necrolysis.
    Vukelíc D; Bozinović D; Tesović G; Dobrić I; Loncarić D; Knezović I; Skerlev M
    Dermatology; 1997; 195(3):307. PubMed ID: 9407193
    [No Abstract]   [Full Text] [Related]  

  • 20. Stevens-Johnson syndrome associated with single high dose of lamotrigine in a patient taking valproate.
    Famularo G; De Simone C; Minisola G
    Dermatol Online J; 2005 Mar; 11(1):25. PubMed ID: 15748566
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.